Scientific Opinion on the safety and efficacy of AGal-Pro BL-L (alpha-galactosidase and endo-1,4-beta-glucanase) as a feed additive for chickens for fattening

zootechnical additive, digestibility enhancers, galactosidase, glucanase, safety, efficacy
First published in the EFSA Journal
18 November 2014
Adopted
28 October 2014
Type
Scientific Opinion

Abstract

The additive AGal-Pro BL-L is a liquid preparation of alpha-galactosidase produced by a genetically modified strain of Saccharomyces cerevisiae and of endo-1,4-beta-glucanase produced by a non-genetically modified strain of Aspergillus niger. The additive is authorised in its solid form for use in chickens for fattening, chickens reared for laying and minor poultry species for fattening as a zootechnical additive in the functional group digestibility enhancers. The applicant seeks the authorisation of the liquid form as a feed additive for chickens for fattening at the same authorised dose range. Taking into account the information provided on the characterisation and manufacturing process of the additive in its liquid form, AGal-Pro BL-L, and the previously submitted data on the solid formulation of the same additive, the FEEDAP Panel concludes that AGal-Pro BL-L is safe and efficacious for the target species at the dose range currently authorised for the product and is safe for the consumer and the environment. The additive is irritant to skin and eyes and a dermal sensitiser and should be considered a respiratory sensitiser.

Panel members at the time of adoption

Gabriele Aquilina, Vasileios Bampidis, Maria De Lourdes Bastos, Lucio Guido Costa, Gerhard Flachowsky, Mikolaj Antoni Gralak, Christer Hogstrand, Lubomir Leng, Secundino López-Puente, Giovanna Martelli, Baltasar Mayo, Fernando Ramos, Derek Renshaw, Guido Rychen, Maria Saarela, Kristen Sejrsen, Patrick Van Beelen, Robert John Wallace and Johannes Westendorf.
Panel on Additives and Products or Substances used in Animal Feed
Contact
FEEDAP [at] efsa.europa.eu
doi
10.2903/j.efsa.2014.3897
EFSA Journal 2014;12(11):3897
Question Number
On request from
European Commission